Question follow-through · 16448
Coronavirus: Vaccination
To ask the Secretary of State for Health and Social Care, whether any of the vials of (a) Pfizer and (b) Moderna covid-19 vaccines supplied to patients in the United Kingdom contained (i) variable and (ii) excessive levels of residual plasmid DNA.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 27 Nov 2024
- Target answer date
- 2 Dec 2024
- Answer
- 2 Dec 2024 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Continuing Care: Dorset · 10 Dec 2024
- Smoking: Young People · 11 Dec 2024
- Smoking: Young People · 11 Dec 2024
- Viral Diseases: Disease Control · 8 Jan 2025
- Vaccine Damage Payment Scheme: Coronavirus · 8 Jan 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
27 Nov 2024
Question tabled
To ask the Secretary of State for Health and Social Care, whether any of the vials of (a) Pfizer and (b) Moderna covid-19 vaccines supplied to patients in the United Kingdom contained (i) variable and (ii) excessive levels of residual plasmid DNA.
2 Dec 2024
Target answer date
Date supplied by the official written-questions record.
2 Dec 2024
Answer published
All batches of the Pfizer and Moderna COVID-19 vaccines released in the United Kingdom to date have passed their release specifications for DNA levels. The specifications are set in line with their respective controlled manufacturing process and in accord...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Continuing Care: Dorset
10 Dec 2024 · To ask the Secretary of State for Health and Social Care, whether there is a maximum time within which applications for NHS Continuing Healthcare funding to NHS Dorset must be actioned; and whether redress is available to applicants whose applications hav
Smoking: Young People
11 Dec 2024 · To ask the Secretary of State for Health and Social Care, what assessment of the probability of an increase in youth smoking rates of illegal tobacco products as a result of the implementation of a generational ban on tobacco sales.
Smoking: Young People
11 Dec 2024 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the probability of young people switching from vaping to smoking tobacco products as a result of the implementation of a generational ban on tobacco sales.
Viral Diseases: Disease Control
8 Jan 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to stop the spread of the HMPV virus from China.
Vaccine Damage Payment Scheme: Coronavirus
8 Jan 2025 · To ask the Secretary of State for Health and Social Care, how many and what proportion of applications to the Vaccine Damage Payment Scheme relating to Covid-19 vaccinations have been (a) made and (b) successful for (i) Vaccine-induced thrombocytopenia an
Vaccine Damage Payment Scheme: Coronavirus
23 Jan 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 October 2024 to Question 10667 on Vaccine Damage Payment Scheme, what discussions he has had with Vaccine Injured and Bereaved UK, and other representatives of those wh
Vaccine Damage Payment Scheme: Coronavirus
23 Jan 2025 · To ask the Secretary of State for Health and Social Care, how many (a) claims and (b) mandatory reversal claims to the Vaccine Damage Payment Scheme on Covid-19 vaccinations have been outstanding for more than (i) six months, (ii) 12 months and (iii) 18 m
Coronavirus: Vaccination
23 Jan 2025 · To ask the Secretary of State for Health and Social Care, with reference to paragraph 20 of his Department's written opening statement to Module 4 of the UK Covid-19 Inquiry of 20 December 2024, INQ000474799, on what evidential basis his Department said t
Coronavirus: Vaccination
23 Jan 2025 · To ask the Secretary of State for Health and Social Care, with reference to paragraph 20 of his Department's written opening statement to Module 4 of the UK Covid-19 Inquiry of 20 December 2024, INQ000474799, on what evidential basis his Department said t
Influenza: Vaccination
23 Jan 2025 · To ask the Secretary of State for Health and Social Care, how many people received a flu vaccine between 1 September and 31 December in each year since 2021.
Coronavirus: Vaccination
5 Feb 2025 · To ask the Secretary of State for Health and Social Care, with reference to paragraph 20 of his Department's Opening Statement to Module 4 of the UK Covid-19 Inquiry, published 15 January 2025, what estimate his Department has made of the number of (a) de
Coronavirus: Vaccination
5 Feb 2025 · To ask the Secretary of State for Health and Social Care, how much his Department has indemnified Astrazeneca in relation to covid-19 vaccine damage claims.